| ID: | 135 | |
|---|---|---|
| Name: | Compound 135 | |
| Description: | Original numeration in publication: 19 | |
| Labels: | Training_set, Thiazolidine‐2, 4‐dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C17H11Cl2N3O3S/c18-11-5-4-10(12(19)8-11)7-13-16(24)22(17(25)26-13)9-15(23)21-14-3-1-2-6-20-14/h1-8H,9H2,(H,20,21,23)/b13-7- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.24 |
El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491 |
| 6.20073 |
Eq1: VEGFR-2 inhibition (Data used to train model) |